Engineered Dendritic Cell Vaccines for Multiple Myeloma

Clinical trial NCT06435910 · RECRUITING

Trial details

NCT number: NCT06435910
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma or Plasmacytoma

Start date: 2024-05-11
Primary completion: 2027-07-11
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.